Upcoming Events

4th Immune Effector Cell Therapies in Multiple Myeloma Workshop

4th Immune Effector Cell Therapies in Multiple Myeloma Workshop

March 24 - 25, 2023 - Hyatt Regency Boston Harbor, Boston, MA and Virtual

Building upon the success of prior workshops, the International Myeloma Society is happy to host the 4th Immune Effector Cell Therapies in Multiple Myeloma Workshop to discuss immune-based therapies in myeloma including the latest CAR T cell and bispecific T cell-engager clinical data, promising preclinical leads, updated correlative analyses exploring predictors of response and resistance mechanisms, and next-generation manufacturing and CAR construct approaches, including “off-the-shelf” allogeneic and NK-cell based strategies.  This year we are also including a session on real-world considerations, including how to potentially sequence immune-based therapies for myeloma, as well as best practices for infection prevention following T cell-directed therapies.

Registration will be open soon!

Preliminary Program 

20th IMS Annual Meeting

20th IMS Annual Meeting

September 27 - 30, 2023 - Athens, Greece

Translational Research Award

2023 Applications are now open!

Career Development Award

2023 Applications are now open!

Recommendations for the Management of Myeloma Patients During the COVID-19 Pandemic

As a response to the current pandemic, the International Myeloma Society Executive Committee has developed the following Recommendations for the Management of Myeloma Patients During the COVID-19 Pandemic. These recommendations include directions for caring for newly diagnosed, elderly, relapsed/refractory and clinical trial patients. Please follow as appropriate for your practice and patient needs. The International Myeloma Society remains committed to keeping patients and physicians safe while providing care and treatment under these extraordinary circumstances.

About Our Publications

As a response to the current pandemic, the International Myeloma Society Executive Committee has developed the following Recommendations for the Management of Myeloma Patients During the COVID-19 Pandemic. These recommendations include directions for caring for newly diagnosed, elderly, relapsed/refractory and clinical trial patients. Please follow as appropriate for your practice and patient needs. The International Myeloma Society remains committed to keeping patients and physicians safe while providing care and treatment under these extraordinary circumstances.

See All Publications

Why Become a Member

The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide. The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.

Stay updated on our Events